Related Experiment Video
Updated: Jan 22, 2026

Modeling Chemotherapy Resistant Leukemia In Vitro
Published on: February 9, 2016
The WNT Pathway Is Relevant for the BCR-ABL1-Independent Resistance in Chronic Myeloid Leukemia
Susanna Grassi1,2, Sara Palumbo3, Veronica Mariotti4
1Hematology Division, University of Pisa, Pisa, Italy.
Abstract:
Notwithstanding the introduction of Tyrosine Kinase Inhibitors (TKIs) revolutionized the outcome of Chronic Myeloid Leukemia (CML), one third of patients still suspends treatment for failure response. Recent research demonstrated that several BCR/ABL1-independent mechanisms can sustain resistance, but the relationship between these mechanisms and the outcome has not yet been fully understood. This study was designed to evaluate in a "real-life" setting if a change of expression of several genes involved in the WNT/BETA-CATENIN, JAK-STAT, and POLYCOMB pathways might condition the outcome of CML patients receiving TKIs. Thus, the expression of 255 genes, related to the aforementioned pathways, was measured by quantitative PCR after 6 months of therapy and compared with levels observed at diagnosis in 11 CML patients, in order to find possible correlations with quality of response to treatment and event-free-survival (EFS). These results were then re-analyzed by the principal component method (PCA) for tempting to better cluster resistant cases. After 12 months of therapy, 6 patients achieved an optimal response and 5 were "resistant;" after application of both statistical methods, it was evident that in all pathways a significant overall up-regulation occurred, and that WNT was the pathway mostly responsible for the TKIs resistance. Indeed, 100% of patients with a "low" up-regulation of this pathway achieved an optimal response vs. 33% of those who showed a "high" gene over-expression (p = 0.016). Analogously, the 24-months EFS resulted significantly influenced by the degree of up-regulation of the WNT signaling: all patients with a "low" up-regulation were event-free vs. 33% of those who presented a "high" gene expression (p = 0.05). In particular, the PCA analysis confirmed the role of WNT pathway and showed that the most significantly up-regulated genes with negative prognostic value were DKK, WNT6, WISP1, and FZD8. In conclusion, our results sustain the need of a wide and multitasking approach in order to understand the resistance mechanisms in CML.
Insights
In Chronic Myeloid Leukemia (CML), WNT pathway gene up-regulation predicts Tyrosine Kinase Inhibitor (TKI) resistance. Low WNT pathway up-regulation correlates with optimal response and event-free survival in CML patients.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Tyrosine Kinase Inhibitors (TKIs) have improved Chronic Myeloid Leukemia (CML) outcomes, but a third of patients develop treatment resistance.
- BCR/ABL1-independent mechanisms contribute to TKI resistance, yet their impact on patient outcomes requires further elucidation.
Purpose of the Study:
- To investigate if changes in gene expression within the WNT/BETA-CATENIN, JAK-STAT, and POLYCOMB pathways influence TKI treatment outcomes in CML patients.
- To identify specific gene expression patterns associated with treatment response and event-free survival in a real-world CML cohort.
Main Methods:
- Quantitative PCR was used to measure the expression of 255 genes across WNT, JAK-STAT, and POLYCOMB pathways in 11 CML patients.
- Gene expression levels at 6 months of TKI therapy were compared to diagnosis levels.
- Principal Component Analysis (PCA) was employed to cluster resistant cases and identify prognostic markers.
Main Results:
- A significant overall up-regulation of genes in all three pathways was observed in resistant CML cases.
- WNT pathway up-regulation was most strongly associated with TKI resistance; 100% of patients with low up-regulation achieved optimal response versus 33% with high up-regulation (p=0.016).
- Event-free survival at 24 months was significantly influenced by WNT pathway up-regulation, with all patients showing low up-regulation remaining event-free compared to 33% with high up-regulation (p=0.05). PCA identified DKK, WNT6, WISP1, and FZD8 as key genes with negative prognostic value.
Conclusions:
- WNT pathway activation is a critical mechanism driving TKI resistance in Chronic Myeloid Leukemia.
- Gene expression profiling, particularly of the WNT pathway, can predict treatment response and survival in CML patients.
- A comprehensive approach is needed to understand and overcome CML resistance mechanisms.
Related Concept Videos
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Introduction to Test of Independence
The test statistic for a test of independence is similar to that of a goodness-of-fit test:
Hypothesis Test for Test of Independence
H0: The two variables (factors)...
Law of Independent Assortment
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...

